Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BrightSpring Health Services (BTSG) EBITDA (2023 - 2025)

Historic EBITDA for BrightSpring Health Services (BTSG) over the last 3 years, with Q3 2025 value amounting to $87.8 million.

  • BrightSpring Health Services' EBITDA rose 20189.71% to $87.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $341.1 million, marking a year-over-year increase of 18265.37%. This contributed to the annual value of $206.4 million for FY2024, which is 4021.88% up from last year.
  • Per BrightSpring Health Services' latest filing, its EBITDA stood at $87.8 million for Q3 2025, which was up 20189.71% from $48.6 million recorded in Q2 2025.
  • In the past 5 years, BrightSpring Health Services' EBITDA ranged from a high of $154.0 million in Q4 2024 and a low of -$52.3 million during Q3 2023
  • Over the past 3 years, BrightSpring Health Services' median EBITDA value was $50.7 million (recorded in 2025), while the average stood at $49.2 million.
  • Its EBITDA has fluctuated over the past 5 years, first crashed by 12974.49% in 2024, then soared by 43087.06% in 2025.
  • Quarter analysis of 3 years shows BrightSpring Health Services' EBITDA stood at $68.3 million in 2023, then surged by 125.54% to $154.0 million in 2024, then plummeted by 42.94% to $87.8 million in 2025.
  • Its last three reported values are $87.8 million in Q3 2025, $48.6 million for Q2 2025, and $50.7 million during Q1 2025.